Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Epigenomics|October 22, 2014
Epigenetic modifications in prostate cancerMarjolaine Ngollo, Aslihan Dagdemir, Seher Karsli-Ceppioglu, et al.
American Journal of Cancer Research|September 2, 2015
DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predispositionMarie Ollier, Nina Radosevic-Robin, Fabrice Kwiatkowski, et al.
Anticancer Research|May 16, 2009
Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohortLuc Fontana, Laetitia Delort, Laurie Joumard, et al.
Omics : a Journal of Integrative Biology|June 14, 2013
Gene panel model predictive of outcome in patients with prostate cancerNadège Rabiau, Yann Dantal, Laurent Guy, et al.
BMC Cancer|April 14, 2017
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progressionMarjolaine Ngollo, Andre Lebert, Marine Daures, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 15, 2008
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnIJianfeng Du, Jing Liu, Han-Zhong Feng, et al.
In Vivo (Athens, Greece)|July 30, 2010
Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cellsAdam Vardi, Remy Bosviel, Nadege Rabiau, et al.
Medical Oncology (Northwood, London, England)|April 11, 2014
3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancerInés Omrane, Amel Mezlini, Olfa Baroudi, et al.
Bulletin Du Cancer|September 19, 2013
[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]Émilie Gadéa, Émilie Thivat, Qian Wang-Lopez, et al.
Epigenomics|October 17, 2018
TIP60: an actor in acetylation of H3K4 and tumor development in breast cancerGaëlle Judes, Lucas Dubois, Khaldoun Rifaï, et al.
Pageof 24